NCT06014788

Brief Summary

The goal of this clinical trial is to compare the effectiveness of NPWTi and NPWT in superficial and deep surgical site infections using an improvised system with continuous lavage with saline and chlorhexidine. The main question it aims to answer is whether the NPWTi is better than conventional NPWT. Participants will be given NPWTi or conventional NPWT. Researchers will compare the two groups to see if NPWTi diminishes the rate of recurrent infections and the number of reoperations, shortens the hospital stay, and alleviates the burden on the hospital staff in comparison to the conventional NPWT.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 17, 2018

Completed
5.5 years until next milestone

First Submitted

Initial submission to the registry

July 28, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 28, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

September 18, 2023

Status Verified

August 1, 2023

Enrollment Period

6.4 years

First QC Date

July 28, 2023

Last Update Submit

September 15, 2023

Conditions

Keywords

NPWTiconventional NPWTsuperficial and deep SSIs

Outcome Measures

Primary Outcomes (3)

  • eradication of the infection

    (negative microbiology or bacterial count \< 103)

    6 weeks

  • the rate of wound closure

    the wound closure by suture or flap

    6 weeks

  • 30-day recurrence rate

    30-day recurrence rate of the infection

    30 days after discharge

Secondary Outcomes (3)

  • hospital stay

    6 weeks

  • number of OR visits

    6 weeks

  • time to wound closure

    6 weeks

Study Arms (2)

NPWTi

EXPERIMENTAL

The whole wound was filled with black foam (Granufoam®, KCI). The instillation was performed via gravity from i.v. bag through a drain put within the foam. Chlorhexidine 0.1% 300 ml in 700 ml saline was used for continuous instillation three times daily (3 L per day) on the background of continuous pressure of 125 mmHg. The dressing changes were performed every 48-72 hours.

Device: NPWTi

conventional NPWT

ACTIVE COMPARATOR

The wound was filled with black foam (Granufoam®, KCI) and covered with plastic folio. A continuous pressure of 125 mmHg was applied using the hospital suction system. The dressing changes were performed every 48 hours.

Device: Conventional NPWT

Interventions

NPWTiDEVICE

The wound was filled with black foam (Granufoam®, KCI). The instillation was performed via gravity from i.v. bag through a drain put within the foam. Chlorhexidine 0.1% 300 ml in 700 ml saline was used for continuous instillation three times daily (3 L per day) on the background of continuous pressure of 125 mmHg.

NPWTi

Conventional NPWT

conventional NPWT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults over 18 years
  • superficial or deep SSIs after laparotomy or laparoscopic surgery

You may not qualify if:

  • persons \< 18 years
  • documented inherited or acquired coagulation disorders or platelet deficiency
  • presence of deep space infection (intra-abdominal abscess or ongoing peritonitis)
  • prosthetic material infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Sugery

Sofia, 1606, Bulgaria

RECRUITING

Study Officials

  • Ventsislav Mutafchiyski, DSc, FACS

    Military Medical Academy, Bulgaria

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2023

First Posted

August 28, 2023

Study Start

January 17, 2018

Primary Completion

June 1, 2024

Study Completion

July 1, 2024

Last Updated

September 18, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations